SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 52 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $68,000 | +44.7% | 11,300 | -0.9% | 0.00% | – |
| Q2 2022 | $47,000 | -42.0% | 11,400 | -47.0% | 0.00% | -100.0% |
| Q1 2022 | $81,000 | +28.6% | 21,500 | +53.6% | 0.00% | 0.0% |
| Q4 2021 | $63,000 | -6.0% | 14,000 | -1.4% | 0.00% | 0.0% |
| Q3 2021 | $67,000 | -22.1% | 14,200 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $86,000 | +19.4% | 14,400 | -7.7% | 0.00% | 0.0% |
| Q4 2020 | $72,000 | -88.6% | 15,600 | -29.1% | 0.00% | -87.5% |
| Q2 2020 | $634,000 | – | 22,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
| Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
| RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
| Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
| Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
| Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
| NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
| SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |